Completeness of prescription information in US commercial claims databases
about
Challenges to integrating pharmacogenetic testing into medication therapy managementMisclassification in administrative claims data: quantifying the impact on treatment effect estimates.Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.Quantification of missing prescriptions in commercial claims databases: results of a cohort study.Evidence of sample use among new users of statins: implications for pharmacoepidemiology.Factors driving anticoagulant selection in patients with atrial fibrillation in the United States.Observation stays in administrative claims databases: underestimation of hospitalized cases.Trends and Determinants of Oral Anti-Diabetic Initiation in Youth with Suspected Type 2 DiabetesDynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design.Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort studyAssessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs.Predictors of gastrointestinal bleeding among patients with atrial fibrillation after initiating dabigatran therapy.Use of Prescription Drug Samples in the USA: A Descriptive Study with Considerations for Pharmacoepidemiology.Comparison of diagnostic evaluations for cough among initiators of angiotensin converting enzyme inhibitors and angiotensin receptor blockers.Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use.A non-experimental study of oral anticoagulation therapy initiation before and after national patient safety goals.Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation.Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial.A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras.The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured PopulationPrimary non-adherence and the new-user design.Injection Testosterone and Adverse Cardiovascular Events: A Case-crossover Analysis.Patient-centered medical homes and oral anticoagulation therapy initiation.Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the "rubber effect".Patchwork of contrasting medication cultures across the USA
P2860
Q28082835-47027554-893E-43A7-8F81-01D3886C5925Q30974376-F813879B-5334-4759-BC53-32EA48C68083Q31102987-63243B5D-F14E-4284-94E8-F493D3E23C4FQ33578224-F4B3B5D0-E704-48CF-ABCB-560F5E7F8755Q34077639-1F0B08A2-456A-4F99-8C74-2D943FCDC225Q35235448-B101047F-DA18-453F-84FA-674210FA7CF9Q35766789-163DBDE6-89AA-4F07-9193-0D5C6F80BBFEQ35824321-542336E0-47D5-4CEC-8EAE-193C71FF3EA3Q35824855-ACFB1B14-D1C9-443D-9E90-18429BF23A5CQ36085794-2440B6D8-D951-4890-B564-2CFF14D21F89Q36284450-85803AAC-20F3-499F-AF65-24D653D30BF9Q36571742-5ABE5FF9-69EC-4E7B-84A1-A7A40C352FA4Q36576444-B0596BEA-F0F1-4DE8-8747-1CB061B44E64Q37066166-9CCE3548-00F8-4130-A79D-9A6F41BF9D09Q37291832-5332EA85-C25B-4422-A67B-FD0024094C3BQ37590855-09E79F04-7074-444B-B5BD-BC6151A7AB4BQ38991392-15233E2A-41E0-4DFE-9500-75643868F0C1Q39360084-3B97F269-6C4E-4076-871E-F0550A4C2BC6Q39787308-FCEA13B6-ED89-4D33-A8AA-B698A542E909Q41917486-1AF12B9B-F6F3-4205-ADC3-ECD4AE9D08E7Q49822791-9D3F8438-A72C-4194-8284-B6BAA4F2367BQ49985009-01405900-8CFC-480E-9214-8207C9A070BDQ51139933-DE5D67CF-3556-45E7-AD8A-1FEF8A7592CDQ55089049-A7D43112-8D2A-4E13-9B37-5DBB9971C673Q57291577-2B960E92-4BA9-4A2C-BFAF-9A63DFFA642F
P2860
Completeness of prescription information in US commercial claims databases
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Completeness of prescription information in US commercial claims databases
@ast
Completeness of prescription information in US commercial claims databases
@en
Completeness of prescription information in US commercial claims databases.
@nl
type
label
Completeness of prescription information in US commercial claims databases
@ast
Completeness of prescription information in US commercial claims databases
@en
Completeness of prescription information in US commercial claims databases.
@nl
prefLabel
Completeness of prescription information in US commercial claims databases
@ast
Completeness of prescription information in US commercial claims databases
@en
Completeness of prescription information in US commercial claims databases.
@nl
P2093
P2860
P356
P1476
Completeness of prescription information in US commercial claims databases
@en
P2093
Akhila Balasubramanian
Cathy W Critchlow
Cynthia D O'Malley
Joel F Farley
M Alan Brookhart
Mary T Roth
P2860
P304
P356
10.1002/PDS.3458
P577
2013-05-21T00:00:00Z